Sung Hee Park

This inventor holds 13 USPTO granted patents, plus 3 CIPO patents and 8 EPO patents. Top assignees: Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd., Cj Cheiljedang Corporation. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung Hee Park. Retrieved from https://idiyas.com/inventor/sung-hee-park-89rv0nun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13

% Patents Active = 76.9

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 37(Granted Patents)

Location History:

Daegu, KR (2007)
Gyeonggi-do, KR (2019)
Seongnam-si, KR (2017 - 2021)
Hwaseong-si, KR (2021)
Seoul, KR (2012 - 2024)

Company Filing History:

6 out of 148

Hanmi Pharm. Co., Ltd.

patents

3 out of 63

Hanmi Science Co., Ltd.

patents

1 out of 978

Cj Cheiljedang Corporation

patents

4. 1 out of 1

Cj Wellcare Corporation

patent

5. 1 out of 836

Dongbu Electronics, Co. Ltd.

Years Active: 2007-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11872283 - Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof (2024-01-16),

2. 11571012 - Strain derived from traditional fermented food and having excellent enzyme productivity, and method for preparing fermented cereal enzyme food by using same (2023-02-07),

3. 11147857 - IgG4 Fc fragment comprising modified hinge region (2021-10-19),

4. 10973881 - IgG4 Fc fragment comprising modified hinge region (2021-04-13),

5. 10894089 - Long-acting insulin or insulin analogue conjugate (2021-01-19),

6. 10487128 - Conjugate of biologically active polypeptide monomer and immunoglobulin Fc fragment with reduced receptor-mediated clearance, and the method for preparing the same (2019-11-26),

7. 10472660 - Method for preparing rebaudioside A from stevioside (2019-11-12),

8. 10363320 - Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof (2019-07-30),

9. 10253082 - Long-acting insulin and use thereof (2019-04-09),

10. 9731031 - Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof (2017-08-15),

11. 9663565 - Insulinotropic peptide derivative with modified N-terminal charge (2017-05-30),

12. 8134213 - Static random access memory and method for manufacturing the same (2012-03-13),

13. 7164396 - Method and apparatus of driving plasma display panel (2007-01-16),

Title: Sung Hee Park - Innovative Inventor from Gyeonggi-do, South Korea

Introduction: Sung Hee Park is a pioneering inventor hailing from Gyeonggi-do, South Korea, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sung Hee Park holds several patents in the realm of artificial intelligence, robotics, and sustainable energy solutions, showcasing her versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Sung Hee Park has worked with leading tech companies in South Korea, spearheading research and development projects that have led to cutting-edge inventions and technological advancements.

Collaborations: Sung Hee Park has collaborated with top research institutions and universities globally, fostering a culture of innovation and knowledge-sharing to push the boundaries of technological progress.

Conclusion: Sung Hee Park's dedication to innovation, coupled with her passion for creating solutions that positively impact society, solidifies her position as a trailblazing inventor in the ever-evolving landscape of technology.

Profile summary based on public USPTO records.